Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen 400 mg Actual Use Study
NCT02294019Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ibuprofen in pain and fever, sponsored by Pfizer. Primary endpoint: Percentage of Participants Taking Greater Than (>) 1200 Milligram (mg) (>3 Caplets) on no More Than 2 Use Days During the Study at 30 days. Started Nov 2014; status: completed.
02
Drugs
ibuprofen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT02294019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294019.